A guide for brand owners and distributors on pharmacopoeial heavy-metal testing protocols for Ras-Rasayan batches and the documentation that should accompany.
Heavy-metal testing for Ras-Rasayan formulations follows pharmacopoeial protocols that verify mercury, lead, arsenic and cadmium remain within permissible limits after the shodhana purification process. A GMP-certified manufacturer tests every batch and provides a certificate of analysis, giving buyers the documentation needed to satisfy regulatory auditors and downstream customers.
Ras-Rasayan is one of the thirteen categories recognised by the Ayurvedic Pharmacopoeia of India, and it is the category that most consistently incorporates processed minerals and metals. Bhasma preparations such as Abhrak Bhasma, Swarna Makshik Bhasma and Tamra Bhasma feature in many classical formulations within this range, as do mercurial preparations like Kajjali and compound products containing purified Shilajit. These ingredients carry inherent heavy-metal profiles by nature, and the entire rationale of classical Ayurvedic processing is to render those metals biologically compatible and within safe thresholds through repeated shodhana, marana and bhavana steps.
When processing is correctly completed and documented, the finished bhasma contains metals in an oxide or nano-particulate form that classical texts identify as therapeutically distinct from the raw metal. When processing is incomplete or raw material quality is substandard, however, residual elemental metal can appear at concentrations that breach permissible limits. For a brand owner or distributor, this translates directly into regulatory exposure: a consignment that fails a heavy-metal screen at customs or during a quality audit creates recall risk, documentation liability and reputational damage. Batch-level testing is therefore the primary instrument of risk management in any Ras-Rasayan supply chain.
The four elements most consistently tested are mercury (Hg), lead (Pb), arsenic (As) and cadmium (Cd). Some laboratories and importing markets also screen for chromium, copper and nickel, particularly for export consignments destined for regulated markets. Permissible limits differ significantly between frameworks. India's Schedule T under the Drugs and Cosmetics Act, the Ayurvedic Pharmacopoeia of India and the requirements of markets such as the United States, Germany or Canada do not always align, and threshold values can vary by an order of magnitude.
A buyer sourcing Ras-Rasayan for export must specify clearly which permissible limits the test should reference. For formulations such as those containing Swarna Bhasma, gold will appear on elemental analysis; a mercury-containing preparation will show mercury. The question is not whether the metal is present but whether the measured concentration falls within the permitted window for that specific formulation category under the applicable standard. Confirming this in writing before placing an order protects both parties and establishes a clear basis for the certificate of analysis.
Shodhana, described in classical texts including the Sharangdhar Samhita and the Rasa Tarangini, is the purification step that most directly determines the heavy-metal profile of the finished product. For mineral and metallic inputs, shodhana typically involves repeated quenching in herbal liquids, churning with wet media and controlled incineration (marana) across multiple cycles. The process aims to remove soluble toxic fractions, reduce particle size to sub-micron scale and convert the metal into a stable oxide form that matches the pharmacopoeial specification for the relevant bhasma.
A buyer should ask any manufacturer to confirm that each shodhana step is documented in the batch manufacturing record, that cycle timing and temperatures are controlled and recorded, and that an in-process quality check confirms the intermediate material before the next stage begins. Under Schedule T GMP, these records are mandatory for any licensed manufacturer. A facility operating under a valid GMP certificate and AYUSH manufacturing licence should hold complete batch records and make them available to quality auditors on request. Verifying that records exist for the sample batch before committing to bulk volume is a straightforward precaution that responsible buyers routinely take.
Atomic absorption spectroscopy (AAS) is the most widely used technique for routine heavy-metal screening in Ayurvedic manufacturing. Inductively coupled plasma optical emission spectrometry (ICP-OES) and inductively coupled plasma mass spectrometry (ICP-MS) offer greater sensitivity and the ability to screen multiple elements simultaneously. The Ayurvedic Pharmacopoeia of India references both AAS and ICP-based methods as acceptable procedures for heavy-metal determination.
For exports to markets where limits are expressed in micrograms per kilogram (parts per billion) rather than milligrams per kilogram (parts per million), ICP-MS is often the necessary method because its detection limits are substantially lower than those achievable with AAS. A brand targeting the European or North American dietary supplement channel may find that AAS data alone does not satisfy the importer's internal specification. Buyers should also confirm whether the testing laboratory holds accreditation from India's National Accreditation Board for Testing and Calibration Laboratories (NABL) or an equivalent international body, since accreditation independently verifies instrument calibration and method validation are current and traceable.
A certificate of analysis for a Ras-Rasayan batch should state the test method used, the instrument type, the laboratory's accreditation status, the unit of measurement, the actual numerical result for each element screened and the permissible limit against which the result is compared. A CoA that reports only "within limits" without stating the actual figure and the reference standard is inadequate for regulatory due diligence or downstream customer audits.
The document should also carry the batch number, manufacturing date and test date, allowing the buyer to confirm that the analysis was performed on the specific batch being supplied rather than on an older representative sample. A certificate of analysis travels with every Raasa Ayurveda consignment as standard. Buyers who wish to verify the parameters covered, or who want to arrange independent third-party retesting on a pre-order sample before committing to full volume, are encouraged to raise those requirements before placing the order.
Beyond the heavy-metal certificate of analysis, a complete quality dossier for a Ras-Rasayan batch should include the batch manufacturing record confirming raw material lot numbers and in-process parameters, the raw material certificates of analysis showing starting material quality, a loss on drying result, an ash value and a microbial limits test result. Where the finished product specification requires it, an X-ray diffraction report or transmission electron microscopy data confirming particle size and crystal structure of the bhasma adds a further layer of assurance that the classical processing was completed as intended.
Not every buyer will need every document for every market or customer, but knowing what is available and confirming it before an audit or regulatory question arises is the mark of a mature sourcing relationship. A manufacturer operating under Schedule T GMP should be able to supply any of these documents on request. Establishing that capability at the sample stage, before bulk orders commence, saves considerable time if documentation requirements become more demanding as your distribution expands.
To discuss your quality verification requirements for Ras-Rasayan bulk supply, contact Raasa Ayurveda in Kanpur on +91 9415128217 or at raasaayurveda@gmail.com. The team can walk you through documentation expectations for contract manufacturing batches and advise on what accompanies each consignment. Enquiries about bulk supply across other classical categories are welcome through the same channel.
Mercury, lead, arsenic and cadmium are the four elements most consistently screened. Some export markets and individual laboratory protocols also test for chromium, copper and nickel. The applicable limits depend on the formulation type and the importing country's regulatory framework, so confirming the required standard before ordering is advisable.
Atomic absorption spectroscopy (AAS) is widely used for routine screening and satisfies most domestic Indian requirements. ICP-MS offers much lower detection limits and is often required when exporting to markets that set thresholds in parts per billion. Ask your manufacturer which method the testing laboratory uses and whether it holds NABL accreditation.
Yes. Requesting a sample and having it independently tested at a laboratory of your choice is standard practice before committing to bulk volume. It confirms that the manufacturer's in-house results are reproducible and that the batch meets the specific limits your market or downstream customer requires. A confident supplier will facilitate this without hesitation.
A Schedule T GMP-compliant manufacturer should hold the complete batch manufacturing record, raw material certificates of analysis, in-process quality check records for each shodhana cycle and the finished product certificate of analysis. These records are mandatory under the Drugs and Cosmetics Act and should be available for any batch supplied to you.
Raasa Ayurveda, 49/72-A, Naughara, Kanpur 208001, Uttar Pradesh, India. Telephone +91 9415128217. Email raasaayurveda@gmail.com.